Prescription peptides
GastrointestinalDog · CatTier BPending availability

KPV

Lysine-Proline-Valine. Anti-inflammatory tripeptide. Emerging in canine and feline chronic enteropathy.

Weight
343 Da
Half-life
Under 20 minutes
Chain
3 amino acids
Studies
18 referenced. Latest 2020.

Prescribe in the platform

Doses are calculated per patient, by weight, in mcg, mL, and syringe units at the compounding partner’s vial strength.

Screen first

Standard screening

Overview

KPV is the C-terminal tripeptide fragment of alpha-melanocyte stimulating hormone. It carries the anti-inflammatory power of alpha-MSH without the melanocortin receptor pigmentation effects.

Small peptide. Big anti-inflammatory footprint. Especially in the gut.

Mechanism of action

  1. 01Suppresses NF-kB signaling in enterocytes and immune cells.
  2. 02Reduces pro-inflammatory cytokine release including TNF-alpha and IL-6.
  3. 03Inhibits mast cell degranulation in dermal and mucosal tissue.
  4. 04Acts independent of MC1R melanocortin receptor. No pigmentation change.
  5. 05Uptake via PepT1 transporter delivers KPV directly to inflamed intestinal tissue.

Molecular data

PropertyValue
Molecular weight343 Da
Chain length3 amino acids
TypeAlpha-MSH fragment
RouteSubcutaneous injection

Species

Dog

Chronic inflammatory bowel disease refractory to first-line therapy. Atopic dermatitis adjunct. Mast cell driven skin inflammation.

Cat

Chronic enteropathy. Feline IBD adjunct. Chronic gingivostomatitis supportive care.

Prescribing indications

  • GastrointestinalSupportedIBD refractory to conventional therapy.
  • DermatologicSupportedAtopic dermatitis adjunct.
  • ImmunologicEmergingMast cell driven inflammation.

Dosing and administration

Starting, maintenance, and loading doses are calculated in the platform for the patient’s weight band, at the vial strength our compounding partner dispenses, and drawn to U-100 syringe units for the client’s dosing card. Any override is logged with your initials.

See the worked dose example

Screening and safety

Screen first

Standard screening

Follow up

Fecal score, appetite, and body condition score. Recheck weight. Measure at baseline and recheck at 4 to 6 weeks with the same measure.

Common pairings

  • KPV + BPC-157CompatibleOften considered together for GI cases.

References

This monograph describes a compounded veterinary medication available by prescription only through a licensed veterinarian inside an active veterinarian-client-patient relationship. Not FDA-approved for animal or human use. Compounded on a patient-specific basis under FDA Guidance for Industry #256. For educational use by licensed veterinarians. Not intended for consumer self-prescribing.